Feb 27, 2020 7:00am EST Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 05, 2020 7:30am EST Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
Nov 26, 2019 7:00am EST Sutro Biopharma to Participate in the 31st Annual Piper Jaffray Healthcare Conference
Nov 08, 2019 7:00am EST Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments
Oct 29, 2019 7:00am EDT Sutro Biopharma Presents Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 Antibody-Drug Conjugate in Patients with Advanced Ovarian Cancer
Oct 16, 2019 4:35pm EDT Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Oct 08, 2019 7:00am EDT Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
